Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 35,965 | 71,308 | 495,729 | 250,456 | 171,017 |
Marketable Securities | 354,939 | 369,933 | 52,368 | 143,197 | 203,210 |
Receivables | 6,851 | 1,419 | 876 | N/A | N/A |
TOTAL | $406,835 | $447,205 | $553,876 | $396,561 | $377,733 |
Non-Current Assets | |||||
PPE Net | 2,098 | 2,089 | 2,283 | 1,783 | 1,618 |
Investments And Advances | 27,026 | 142,935 | 67,097 | 17,546 | 54,305 |
Other Non-Current Assets | 16,430 | 18,154 | 19,814 | 662 | 1,541 |
TOTAL | $45,554 | $163,178 | $89,194 | $19,991 | $57,464 |
Total Assets | $452,389 | $610,383 | $643,070 | $416,552 | $435,197 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 4,698 | 2,784 | 1,741 | 4,217 | 16,237 |
Accrued Expenses | 30,967 | 21,633 | 12,853 | 15,262 | 11,052 |
Other current liabilities | N/A | N/A | N/A | 342 | 871 |
TOTAL | $37,442 | $26,054 | $16,099 | $19,821 | $29,535 |
Non-Current Liabilities | |||||
Other Non-Current Liabilities | 326,844 | 322,226 | 270,543 | 0 | 654 |
TOTAL | $326,844 | $322,226 | $270,543 | $N/A | $654 |
Total Liabilities | $364,286 | $348,280 | $286,642 | $19,821 | $30,189 |
Shareholders' Equity | |||||
Shares Outstanding, K | 26,763 | 27,931 | 27,672 | 27,366 | 27,265 |
Common Shares | 27 | 29 | 28 | 27 | 27 |
Retained earnings | -614,096 | -450,477 | -321,753 | -263,957 | -244,026 |
Other shareholders' equity | -797 | -5,246 | -422 | -4 | 338 |
TOTAL | $88,103 | $262,103 | $356,428 | $396,731 | $405,008 |
Total Liabilities And Equity | $452,389 | $610,383 | $643,070 | $416,552 | $435,197 |